US2019242885A1PendingUtilityA1
Digital protein sensing chip and methods for detection of low concentrations of molecules
Est. expiryApr 16, 2034(~7.7 yrs left)· nominal 20-yr term from priority
G01N 33/5438B01L 3/502715B01L 3/502761B01L 2300/0887G01N 33/48721B01L 2200/10B01L 2300/0861B01L 2300/0645
62
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
A sensing device is provided that includes a tunnel junction created by forming a hole in a layered tunnel junction (for example). A chemically, well-defined surface may be formed by coupling affinity reagents to the electrodes, which, by these means, the surface may be configured to be selective for a particular analyte.
Claims
exact text as granted — not AI-modified1 . A device for detecting the binding of a molecule to a cognate ligand, comprising:
a first planar electrode having a length, a width and a thickness; an insulating layer having a length, a width and a thickness; a second planar electrode having a length, a width and a thickness; an opening between the electrodes configured to expose the gap between them and establishing an electrodes-insulating layer junction, wherein the opening is spaced away from the perimeter of each electrode; one or more recognition molecules comprising a cognate ligand; a chemical group configured to couple the cognate ligand to at least one of the electrodes; and a reference electrode in communication with at least one of the electrodes.
2 . The device of claim 1 , wherein the reference electrode is configured with a substantially constant potential difference with respect to at least one of the electrodes.
3 . The device of claim 1 , wherein the cognate ligand comprises at least one of an antibody, a Fab fragment, an aptamer and a peptide configured to bind to one or more protein targets.
4 . The device of claim 1 , wherein the device is configured to detect single molecular binding events corresponding to low concentration sample solutions.
5 . The device of claim 1 , wherein the device is configured for sequencing a peptide chain.
6 . A system for detecting the binding of a molecule to a cognate ligand, comprising:
the device of claim 1 ; and purification means for purifying a patient serum sample for obtaining one or more target proteins.
7 . The system of claim 6 , wherein the purification means comprises a lab-on-a-chip.
8 . The system of claim 6 , further comprising a pair of fluid chambers, the device formed between the pair of fluid chambers.
9 . The system of claim 8 , wherein the pair of fluid chamber are in fluid communication via the opening in the device.
10 . A method for detecting at least one binding event between a recognition molecule and a target molecule, comprising:
providing the device of claim 1 ; providing a substantially fixed bias between the electrodes; flowing a sample solution adjacent the junction; recording current signals generated as a result of one or more binding events between one or more molecules in the sample and corresponding recognition molecules; and determining at least one of a number and type of molecules present in a sample solution based on the characteristics of the signal generated as each type of molecule binds.
11 . The method according to claim 10 , further comprising recording at least one of the number and type of molecules determined.
12 . The method according to claim 10 , wherein the characteristics comprise at least one of baseline current, peak current above a baseline, peak width, peak shape as encoded by Fourier, wavelet or Cepstrum component amplitudes, and flatness of the peak top expressed as root mean square signal variation.
13 . The method according to claim 10 , further comprising at least one of recording and counting signals generated by single molecule binding events of a plurality of protein variants contained in the sample solution.
14 . The method according to claim 10 , further comprising providing the target molecule, including:
providing a sample to a first channel of a processing device, the sample including cells containing the target molecule, the first channel including antibodies for capturing the cells in the sample; lysing the captured cells to generate a lysate including the target molecule; eluting the lysate into a second channel including antibodies for binding the target molecule; generating fragments of the target molecule from the bound target molecule; and providing the fragments of the target molecule as the target molecule to the device.
15 . The method according to claim 14 , wherein the sample includes blood cells, wherein the target molecule includes a protein, and wherein the fragments of the target molecule includes peptides of the protein.
16 . The method according to claim 14 , the generating the fragments further including capturing a portion of the fragment of the target molecule, the providing the fragments including providing the portion of the fragment of the target molecule to the device.
17 . The method according to claim 14 , herein the fragments of the target molecule includes peptides of the protein, further comprising, prior to providing the fragments, modifying the fragments to ligate a charged peptide to the N terminus of the peptides of the protein, the providing including providing the modified fragments as the target molecule to the device.
18 - 28 . (canceled)Join the waitlist — get patent alerts
Track US2019242885A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.